Merit Medical Systems, Inc., a renowned entity in healthcare innovation, announced a significant development for patients dealing with knee osteoarthritis. Their product, Embosphere® Microspheres, received certification for use in genicular artery embolisation (GAE) within the European Union. This advancement provides a new, non-surgical alternative to address knee pain caused by osteoarthritis, presenting a compelling option for enhancing mobility and reducing the need for invasive surgery.
Significance of Genicular Artery Embolisation
Genicular artery embolisation is gaining attention as an alternative therapy in musculoskeletal treatment. By limiting blood supply to the inflamed joint lining, the technique alleviates discomfort and boosts joint mobility. This new indication for Embosphere signals progress in musculoskeletal care, aligning with the global pursuit of minimally invasive solutions for pain management.
Clinical Evidence and Outcomes
The Embosphere Microspheres have been validated through robust clinical outcomes. Over 75% of patients undergoing GAE with Embosphere reported substantial pain reduction, observed for up to 24 months post-treatment. The procedure also consistently outperformed corticosteroid injections in terms of pain relief and improved life quality within three months, underlining its efficacy and long-term benefits.
As for characteristics, the microspheres, crafted from a special tris-acrylic co-polymer, ensure firm and effective blockage of the targeted blood pathways—a critical factor for achieving desired outcomes in GAE. This feature propels Embosphere to the top of its class compared to similar devices, positioning it as a leading choice for those seeking reliable therapeutic interventions.
– GAE provides a significant alternative to knee osteoarthritis surgery.
– Embosphere’s performance in GAE supersedes traditional corticosteroid injections.
– The current trend places emphasis on non-surgical, pain-management strategies in musculoskeletal care.
The revelation that Embosphere Microspheres can treat knee osteoarthritis via genicular artery embolisation marks a major leap forward in orthopedic treatments. Healthcare providers now have a technologically advanced, non-surgical option to offer patients a quicker recovery and improved daily living without surgery. Looking ahead, the continued development and application of embolotherapy products like Embosphere may further transform treatment standards, benefiting providers and patients globally. As healthcare seeks smarter solutions, minimally invasive products like Embosphere are poised to become a benchmark for innovative and effective patient care.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
